StockSelector.com
  Research, Select, & Monitor Sunday, February 23, 2020 6:03:57 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Revance Therapeutics, Inc.$27.81$.23.83%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Revance Therapeutics, Inc. has an overall rank of 4274 out of 6020 stocks based on 3 positive rankings and 3 negative rankings.

Positive Rankings
90 Day Gain
Revance Therapeutics rank is 145
10 Day Gain
Revance Therapeutics rank is 821
Low Put/Call
Revance Therapeutics has a low Put/Call ratio of 0.37 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Revance Therapeutics is ranked 985.
Negative Rankings
Overbought Stochastics
Revance Therapeutics rank is 153
Overbought RSI
The 14 Day Relative-Strength Index for Revance Therapeutics is 77.3. An RSI above 70 indicates the stock is overbought. Among companies with a high RSI, Revance Therapeutics is ranked 176.
High vPut/Call
Revance Therapeutics has a high Put/Call ratio of 1.09 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Revance Therapeutics is ranked 1103.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.